Technical Analysis for PFNX - Pfenex Inc.

Grade Last Price % Change Price Change
grade F 3.93 -1.75% -0.07
PFNX closed down 1.75 percent on Friday, January 18, 2019, on 73 percent of normal volume. It ran into resistance at its 50 day moving average. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical PFNX trend table...

Date Alert Name Type % Chg
Jan 18 50 DMA Resistance Bearish 0.00%
Jan 18 Shooting Star Candlestick Bearish 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 17 50 DMA Resistance Bearish -1.75%
Jan 17 Wide Bands Range Expansion -1.75%
Jan 16 Pocket Pivot Bullish Swing Setup -0.25%
Jan 16 NR7 Range Contraction -0.25%
Jan 16 Wide Bands Range Expansion -0.25%
Jan 15 Wide Bands Range Expansion 0.00%
Jan 14 50 DMA Resistance Bearish -2.72%

Older signals for PFNX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Pfenex Inc., a clinical-stage biotechnology company, is engaged in the development of biosimilar therapeutics. Its lead product candidate includes PF582, a biosimilar candidate to Lucentis that is in Phase Ib/IIa trials in patients with wet age-related macular degeneration. The company also develops PF530, an interferon beta-1b biosimilar candidate to the Betaseron to reduce the relapses in patients with relapsing forms of multiple sclerosis; PF694, an interferon alpha-2a biosimilar candidate to the reference product Pegasys; and other biosimilar candidates. In addition, it develops PF708, a teriparatide generic peptide product candidate to the reference listed drug Forteo; Px563L, an anthrax vaccine candidate based on a recombinant modified form of the protective antigen; and Px533, a prophylactic vaccine candidate to protect against malaria infection. The company has collaboration with Strides Arcolab Limited for the development of PF530. Pfenex Inc. is headquartered in San Diego, California.
Is PFNX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 8.42
52 Week Low 2.85
Average Volume 73,680
200-Day Moving Average 4.9896
50-Day Moving Average 4.0672
20-Day Moving Average 3.8115
10-Day Moving Average 4.021
Average True Range 0.3121
ADX 14.76
+DI 21.1913
-DI 14.8341
Chandelier Exit (Long, 3 ATRs ) 3.3937
Chandelier Exit (Short, 3 ATRs ) 4.0663
Upper Bollinger Band 4.4003
Lower Bollinger Band 3.2227
Percent B (%b) 0.6
BandWidth 30.895973
MACD Line 0.011
MACD Signal Line -0.026
MACD Histogram 0.037
Fundamentals Value
Market Cap 92.46 Million
Num Shares 23.5 Million
EPS 0.06
Price-to-Earnings (P/E) Ratio 65.50
Price-to-Sales 1.08
Price-to-Book 1.09
PEG Ratio -0.03
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.40
Resistance 3 (R3) 4.44 4.34 4.32
Resistance 2 (R2) 4.34 4.22 4.31 4.29
Resistance 1 (R1) 4.13 4.15 4.08 4.09 4.27
Pivot Point 4.03 4.03 4.00 4.00 4.03
Support 1 (S1) 3.82 3.91 3.77 3.78 3.59
Support 2 (S2) 3.72 3.84 3.69 3.57
Support 3 (S3) 3.51 3.72 3.54
Support 4 (S4) 3.47